• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

House Unanimously Passes Bills Updating FDA’s Orange and Purple Books

cafead

Administrator
Staff member
  • cafead   May 08, 2019 at 05:22: PM
via The US House of Representatives on Wednesday unanimously passed two bills that would increase the utility of the US Food and Drug Administration’s (FDA) Orange Book for generic drugmakers and Purple Book for biosimilar developers.

article source